Get started
REGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INC

REGENERON PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Forecast

REGN chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
168.81MXN
Revenue estimate
‪53.46 B‬MXN

Key stats

Market capitalization
‪1.67 T‬MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
27.34
Basic EPS (TTM)
629.22MXN
Net income (FY)
‪67.15 B‬MXN
Revenue (FY)
‪222.80 B‬MXN
Shares float
‪105.09 M‬
Beta (1Y)
0.54

About Regeneron Pharmaceuticals, Inc.

Sector
Health Technology
CEO
Leonard S. Schleifer
Headquarters
Tarrytown
Website
regeneron.com
Employees (FY)
‪13.45 K‬
Founded
1988
FIGI
BBG00JX0QK71
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Sparks

Curated watchlists where REGN is featured.

See all sparks 

Frequently Asked Questions

The current price of REGN is 15516.00 MXN — it has decreased by 4.41% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange REGENERON PHARMACEUTICALS INC stocks are traded under the ticker REGN.
REGENERON PHARMACEUTICALS INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
REGN stock is 5.23% volatile and has beta coefficient of 0.54. Check out the list of the most volatile stocks — is REGENERON PHARMACEUTICALS INC there?
REGN earnings for the last quarter are 202.02 MXN per share, whereas the estimation was 186.19 MXN resulting in a 8.50% surprise. The estimated earnings for the next quarter are 182.26 MXN per share. See more details about REGENERON PHARMACEUTICALS INC earnings.
REGENERON PHARMACEUTICALS INC revenue for the last quarter amounts to ‪58.61 B‬ MXN despite the estimated figure of ‪56.34 B‬ MXN. In the next quarter revenue is expected to reach ‪55.96 B‬ MXN.
Yes, you can track REGENERON PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
REGN stock has fallen by 4.66% compared to the previous week, the month change is a 4.66% fall, over the last year REGENERON PHARMACEUTICALS INC has showed a 4.75% decrease.
REGN net income for the last quarter is ‪19.70 B‬ MXN, while the quarter before that showed ‪17.57 B‬ MXN of net income which accounts for 12.12% change. Track more REGENERON PHARMACEUTICALS INC financial stats to get the full picture.
Today REGENERON PHARMACEUTICALS INC has the market capitalization of ‪1.67 T‬, it has increased by 1.08% over the last week.
No, REGN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, REGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENERON PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 28, 2024, the company has ‪13.45 K‬ employees. See our rating of the largest employees — is REGENERON PHARMACEUTICALS INC on this list?
We've gathered analysts' opinions on REGENERON PHARMACEUTICALS INC future price: according to them, REGN price has a max estimate of 20311.94 MXN and a min estimate of 12299.91 MXN. Read a more detailed REGENERON PHARMACEUTICALS INC forecast: see what analysts think of REGENERON PHARMACEUTICALS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENERON PHARMACEUTICALS INC EBITDA is ‪79.86 B‬ MXN, and current EBITDA margin is 36.36%. See more stats in REGENERON PHARMACEUTICALS INC financial statements.